Improve Lung Regeneration Through Targeting Tuft Cells Following Viral Infection
通过靶向病毒感染后的簇细胞改善肺再生
基本信息
- 批准号:10298186
- 负责人:
- 金额:$ 63.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-20 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAblationAcute Lung InjuryAddressAffectAlternative TherapiesAlveolarAlveolar CellAlveolusAttenuatedBasal CellBrush CellCOVID-19COVID-19 pandemicCOVID-19 patientCationsCell Differentiation processCellsChemosensitizationChronic DiseaseClinicalCoronavirusDataDiseaseDistalEpithelial CellsExhibitsFibrosisFinancial HardshipFoundationsGeneticGenetic TranscriptionGoblet CellsHealthHyperplasiaImpairmentIn Situ HybridizationInfectionInflammationInfluenzaInfluenza A Virus, H1N1 SubtypeIntestinesKnock-in MouseLigandsLungLung diseasesMediatingMetaplasiaModelingMolecularMucous body substanceMusNatural regenerationOrganoidsOxidesPathway interactionsPeripheralPharmacologic SubstancePhasePlayReagentRoleSARS-CoV-2 infectionSignal TransductionStructureStructure of parenchyma of lungTRPM5 geneTestingTissuesVirusVirus Diseasesacute infectionalveolar epitheliumcell typecytokineefficacy testingexperimental studyfluhelminth infectionimprovedinfluenza infectioninsightlung developmentlung injurylung regenerationmortalitymouse modelnotch proteinnovelnovel strategiesnovel therapeutic interventionparacrinereceptorregeneration functionrepairedseasonal influenzasingle cell analysisstem cellstargeted treatmenttherapeutic targettriphenylphosphine
项目摘要
ABSTRACT
Seasonal influenza and the current COVID-19 pandemic cause serious health and financial burdens. Severe viral infection
leads to acute lung injury, inflammation and contributes to tissue remodeling and fibrosis. Intriguingly, clusters of ectopic
basal cells (also known as pod cells) are present in the peripheral lungs during acute infection and remodeling phases. Initial
studies indicated that these cells were able to generate type I and II alveolar epithelial cells (AECs). Nevertheless,
subsequent lineage tracing studies revealed that pod cells had minimal if any contribution to alveolar regeneration.
Moreover, our preliminary data suggest that pod cells give rise to goblet cells, resulting in mucous metaplasia accompanied
by the presence of chemosensory tuft cells (also known as brush cells). Significantly, genetic ablation of tuft cells promotes
the differentiation of pod cells into AECs. Our further analyses revealed that tuft cells express the Notch ligand Jag2,
whereas pod cells express Notch receptors with prominent Notch activation. Consistently, Notch inhibition led to reduced
mucous metaplasia and improved alveolar regeneration. We therefore hypothesize that tuft cells promote mucous
metaplasia of pod cells and impede alveolar regeneration via paracrine JAG2/Notch activation upon viral infection.
Two specific aims were devised to test the hypothesis. Aim1: To address the molecular mechanisms by which tuft cells
promote mucous metaplasia following viral infection. Aim2: To promote the differentiation of pod cells into AECs through
targeting JAG2 in tuft cells. In this aim we will combine a novel COVID-19 mouse model and pod cell organoids
established from COVID-19 patient lungs to test the efficacy of a JAG/Notch decoy in promoting alveolar regeneration.
Together this proposal will not only elucidate the disease mechanisms impairing lung regeneration post viral infection, but
also offer new therapeutic approaches to treat lungs infected by influenza and coronavirus.
抽象的
季节性流感和目前的Covid-19大流行造成了严重的健康和经济负担。严重的病毒感染
导致急性肺损伤,炎症,并导致组织重塑和纤维化。有趣的是,异位簇
在急性感染和重塑阶段,基底细胞(也称为POD细胞)存在于外周肺中。最初的
研究表明,这些细胞能够生成I型和II型肺泡上皮细胞(AEC)。尽管如此,
随后的谱系追踪研究表明,如果对肺泡再生有任何贡献,POD细胞的含量很小。
此外,我们的初步数据表明,POD细胞会产生杯状细胞,从而导致粘液上流如鼻。
通过化学感应簇细胞(也称为刷细胞)的存在。值得注意的是,簇细胞的遗传消融促进
POD细胞分化为AEC。我们的进一步分析表明,簇细胞表达了Notch配体JAG2,
而POD细胞表达具有突出缺口激活的Notch受体。一致地抑制导致减少
粘液化生和改善的肺泡再生。因此,我们假设簇细胞促进粘液
POD细胞的化生和病毒感染后通过旁分泌Jag2/Notch激活阻碍肺泡再生。
设计了两个具体的目标来检验该假设。 AIM1:解决簇细胞的分子机制
病毒感染后促进粘液化生。 AIM2:通过
靶向簇细胞中的JAG2。在此目的中,我们将结合一种新型的Covid-19小鼠模型和POD细胞器官
从COVID-19患者肺建立,以测试JAG/Notch诱饵在促进肺泡再生方面的功效。
该提案在一起不仅会阐明病毒感染后疾病机制损害肺部再生,而且还会削弱
还提供新的治疗方法来治疗受流感和冠状病毒感染的肺部。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jianwen Que其他文献
Jianwen Que的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jianwen Que', 18)}}的其他基金
Tuft Cells Modulate Macrophage Response Following Lung Viral Infection
簇细胞调节肺部病毒感染后的巨噬细胞反应
- 批准号:
10453066 - 财政年份:2022
- 资助金额:
$ 63.44万 - 项目类别:
Gastroesophageal junction stem cells as the origin of Barretts esophagus and cancer
胃食管连接处干细胞是巴雷特食管和癌症的起源
- 批准号:
10506097 - 财政年份:2022
- 资助金额:
$ 63.44万 - 项目类别:
SOX4-Mediated Transcription Program in Esophageal Adenocarcinoma
SOX4 介导的食管腺癌转录程序
- 批准号:
10662315 - 财政年份:2022
- 资助金额:
$ 63.44万 - 项目类别:
Depletion of Barrett's and Esophageal Adenocarcinoma Cells with CRISPR/Cas13d
使用 CRISPR/Cas13d 消除 Barrett 细胞和食管腺癌细胞
- 批准号:
10831233 - 财政年份:2022
- 资助金额:
$ 63.44万 - 项目类别:
SOX4-Mediated Transcription Program in Esophageal Adenocarcinoma
SOX4 介导的食管腺癌转录程序
- 批准号:
10407747 - 财政年份:2022
- 资助金额:
$ 63.44万 - 项目类别:
Tuft Cells Modulate Macrophage Response Following Lung Viral Infection
簇细胞调节肺部病毒感染后的巨噬细胞反应
- 批准号:
10555330 - 财政年份:2022
- 资助金额:
$ 63.44万 - 项目类别:
Improve Lung Regeneration Through Targeting Tuft Cells Following Viral Infection
通过靶向病毒感染后的簇细胞改善肺再生
- 批准号:
10679030 - 财政年份:2021
- 资助金额:
$ 63.44万 - 项目类别:
Improve Lung Regeneration Through Targeting Tuft Cells Following Viral Infection
通过靶向病毒感染后的簇细胞改善肺再生
- 批准号:
10471373 - 财政年份:2021
- 资助金额:
$ 63.44万 - 项目类别:
相似国自然基金
面向肝癌射频消融的智能建模与快速动力学分析方法研究及其临床验证
- 批准号:62372469
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
IRF9调控CD8+T细胞介导微波消融联合TIGIT单抗协同增效抗肿瘤的作用机制
- 批准号:82373219
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
玛纳斯河流域上游吸收性气溶胶来源及其对积雪消融的影响研究
- 批准号:42307523
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
建立可诱导细胞消融系统揭示成纤维细胞在墨西哥钝口螈肢体发育及再生中的作用
- 批准号:32300701
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肿瘤源PPIA介导结直肠癌肝转移射频消融术残瘤化疗抵抗的机制研究
- 批准号:82302332
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Tuft Cells Modulate Macrophage Response Following Lung Viral Infection
簇细胞调节肺部病毒感染后的巨噬细胞反应
- 批准号:
10453066 - 财政年份:2022
- 资助金额:
$ 63.44万 - 项目类别:
Pulmonary Vascular Regeneration via Venous Endothelial Progenitors
通过静脉内皮祖细胞进行肺血管再生
- 批准号:
10532604 - 财政年份:2022
- 资助金额:
$ 63.44万 - 项目类别:
Pulmonary Vascular Regeneration via Venous Endothelial Progenitors
通过静脉内皮祖细胞进行肺血管再生
- 批准号:
10753505 - 财政年份:2022
- 资助金额:
$ 63.44万 - 项目类别:
Tuft Cells Modulate Macrophage Response Following Lung Viral Infection
簇细胞调节肺部病毒感染后的巨噬细胞反应
- 批准号:
10555330 - 财政年份:2022
- 资助金额:
$ 63.44万 - 项目类别:
Improve Lung Regeneration Through Targeting Tuft Cells Following Viral Infection
通过靶向病毒感染后的簇细胞改善肺再生
- 批准号:
10679030 - 财政年份:2021
- 资助金额:
$ 63.44万 - 项目类别: